Collegium Pharmaceutical Inc (COLL)
37.51
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
37.53
+0.02
(+0.05%)
After-Hours: 20:00
Collegium Pharmaceutical Total Liabilities (Quarterly): 947.88M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 947.88M |
| September 30, 2023 | 998.70M |
| June 30, 2023 | 1.013B |
| March 31, 2023 | 1.035B |
| December 31, 2022 | 979.29M |
| September 30, 2022 | 1.004B |
| June 30, 2022 | 1.048B |
| March 31, 2022 | 1.050B |
| December 31, 2021 | 489.15M |
| September 30, 2021 | 490.71M |
| June 30, 2021 | 460.67M |
| March 31, 2021 | 476.03M |
| December 31, 2020 | 457.81M |
| September 30, 2020 | 471.16M |
| June 30, 2020 | 491.10M |
| March 31, 2020 | 493.73M |
| December 31, 2019 | 218.87M |
| September 30, 2019 | 219.72M |
| June 30, 2019 | 215.76M |
| Date | Value |
|---|---|
| March 31, 2019 | 208.01M |
| December 31, 2018 | 199.66M |
| September 30, 2018 | 575.73M |
| June 30, 2018 | 590.65M |
| March 31, 2018 | 605.46M |
| December 31, 2017 | 31.49M |
| September 30, 2017 | 26.40M |
| June 30, 2017 | 29.00M |
| March 31, 2017 | 25.48M |
| December 31, 2016 | 27.11M |
| September 30, 2016 | 24.40M |
| June 30, 2016 | 21.07M |
| March 31, 2016 | 14.61M |
| December 31, 2015 | 12.65M |
| September 30, 2015 | 13.49M |
| June 30, 2015 | 11.76M |
| March 31, 2015 | 12.95M |
| December 31, 2014 | 17.33M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
215.76M
Minimum
Jun 2019
1.050B
Maximum
Mar 2022
661.05M
Average
491.10M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 82.23M |
| Immunogen Inc (DELISTED) | 260.50M |
| AnaptysBio Inc | 364.29M |
| Recursion Pharmaceuticals Inc | 190.26M |
| Nuvalent Inc | 31.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.143B |
| Shareholders Equity (Quarterly) | 195.43M |
| Debt to Equity Ratio | 3.414 |
| Current Ratio | 1.174 |
| Net Debt Paydown Yield | 1.15% |